tiprankstipranks

Paul Hastings Insider Profile

11 Followers
Paul Hastings, CEO, Director at Nkarta, holds 390.25K shares in Nkarta (Ticker: NKTX), holds ― shares in enGene Holdings (Ticker: ENGN), holds 12.72K shares in Pacira Pharmaceuticals (Ticker: PCRX).
tipranks
Paul Hastings

Paul Hastings
Nkarta (NKTX)
CEO, Director

Ranked #16,085 out of 109,030 Corporate Insiders

Profitable Transactions

50%
5 out of 10 Profitable Transactions

Average Return

+12.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
77.87%
22.13%
0.00%
0.00%
A breakdown of Paul Hastings's holdings

Insider Roles

Nkarta
(NKTX)
CEO, Director
Pacira Pharmaceuticals
(PCRX)
Director
enGene Holdings
(ENGN)
Director
Protara Therapeutics
(TARA)
Director
Roles that Paul Hastings holds in companies

Most Profitable Insider Trade

Stock:
Nkarta
(NKTX)
Rating:Informative Sell
Date:Jan 18, 2024 - Jan 18, 2025
Return:+70.90%
The most profitable trade made by Paul Hastings

Paul Hastings's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Nkarta
Jun 22, 2026
CEO, Director
Uninformative Sell
4.81K
$1.14M
enGene Holdings
Director
Protara Therapeutics
Oct 20, 2016
Director
Uninformative Buy
OMED
OncoMed Pharma
Oct 12, 2017
Informative Sell
5.93K
$308.71K
Pacira Pharmaceuticals
Jun 13, 2024
Director
Uninformative Buy
$322.68K
RLYP
Relypsa Inc
Jun 23, 2016
Uninformative Buy
$112.22K
NVLNF
Novelion Therapeutics
$6.67K
List of latest transactions for each holding click on a transaction to see Paul Hastings's performance on stock

Paul Hastings insider profile FAQ

What is the percentage of profitable transactions made by Paul Hastings?
The percentage of profitable transactions made by Paul Hastings is 50%.
    What is the average return per transaction made by Paul Hastings?
    The average return per transaction made by Paul Hastings is 12.70%.
      What stocks does Paul Hastings hold?
      Paul Hastings holds: NKTX, ENGN, TARA, OMED, PCRX, RLYP, NVLNF stocks.
        What was Paul Hastings’s latest transaction?
        Paul Hastings latest transaction was an Uninformative Sell of $4.81K.
          What was Paul Hastings's most profitable transaction?
          Paul Hastings’s most profitable transaction was an Informative Sell of NKTX stock on January 18, 2024. The return on the trade was 70.90%.
            What is Paul Hastings's role in Nkarta?
            Paul Hastings's role in Nkarta is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.